Photo via New York Post

FDA inspectors found bugs, mold at two Chinese factories that make GLP-1 weight-loss drugs: report

Read the original at New York Post ↗
Cite

Lang, E. (2026, October 15). FDA inspectors found bugs, mold at two Chinese factories that make GLP-1 weight-loss drugs: report. New York Post. https://nypost.com/2026/10/15/business/fda-inspectors-found-bugs-mold-at-two-chinese-factories-that-make-glp-1-weight-loss-drugs-report/

Dated from the outlet's own feed. Check the original for its byline.

New York Post · collected 2026-10-15 · by Emily Lang

Quick Summary

FDA inspectors discovered significant contamination issues at two Chinese factories producing components for GLP-1 weight-loss drugs like semaglutide and tirzepatide. The inspection uncovered mold, bugs in the ceiling, and improper disposal of samples by factory employees attempting to hide documents from investigators. One facility, operated by Chengdu Shengnuo Biopharm Co., had staff pouring out product samples into sinks and moving documents hastily when inspectors arrived. Both companies were placed on the FDA’s import list due to these findings, indicating that their products could be seized at US borders if imported.
Written by AI on 2026-10-15, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

US inspectors documented severe hygiene issues at two Chinese factories producing key components for compounded GLP-1 drugs popular in America, including black mould and bug infestations. The inspections, conducted under a Freedom of Information Act request, revealed that employees at one plant were attempting to hide paperwork and pouring out product samples when inspectors arrived. These plants manufacture semaglutide and tirzepatide, the active ingredients in weight-loss drugs from Novo Nordisk and Eli Lilly & Co., for custom-made versions not approved by regulators. The Food and Drug Administration (FDA) has placed both companies on its import-alert list, potentially blocking their products from entering the US market. China is a major supplier of these active ingredients to drug compounders that produce cheaper copies of popular weight-loss medications.

Written for “FDA Inspectors Find Issues In Chinese Plants” on 2026-11-21, grounded in this article and the 1 other(s) covering the same event.

How they differ

2 outlets covered “FDA Inspectors Find Issues In Chinese Plants”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

New York PostThis outlet15 Oct

FDA inspectors discovered significant contamination issues at two Chinese factories producing components for GLP-1 weight-loss drugs like semaglutide and tirzepatide. The inspection uncovered mold, bugs in the ceiling, and improper disposal of samples by factory employees attempting to hide documents from investigators. One facility, operated by Chengdu Shengnuo Biopharm Co., had staff pouring out product samples…

FDA inspectors found bugs, mold at two Chinese factories that make GLP-1 weight-loss drugs: report (this article)
The Straits Times15 Oct

US inspectors found severe hygiene issues at two Chinese factories producing key components for popular weight-loss drugs like semaglutide and tirzepatide. Problems included black mould on equipment, floor contamination, and insect infestations. Employees attempted to hide documentation from investigators, leading the FDA to add these companies to its import alert list, preventing their products from entering the US…

Black mould, bugs found at Chinese plants making GLP-1 compounding agents →

Compared with similar articles

This article reads unscored and hedges 39% of its claims. Each row says how that neighbour differs.
The Straits Times
Hedges 7 of 27 claims Outlet record 64/100
New York Post
Hedges 5 of 16 claims Outlet record 66/100
“Article A describes contaminated factories producing unauthorized drugs, while Article B reports deaths from bootleg versions of an unapproved drug. Though related, they describe different incidents.”

Story

FDA Inspectors Find Issues In Chinese Plants
Health · 2 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
18
sentences that state something as happening or true
Uncertain
39%
7 of 18 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-15 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

New York Post · 21706 article(s) · 41 correction(s) detected
Running correction rate · 41 correction(s)

Who wrote this

Emily Lang
29 article(s) here · 1 carrying a prediction
More than half of Anthropic employees — or 2,800 of the company’s workforce of 5,000 — will be worth at least $10 million, according to estimates by Hill.com.
The apparent outage comes with GTA 6 set to hit consoles at midnight Thursday.
Reuters could not immediately ascertain whether the code was successfully used in each case, or the extent of any resulting hacks.
Gábor Lukács, an air passenger rights advocate, told The Post that this type of situation would have been handled very differently in Europe. “It would be viewed as extraordinary circumstances, under the European or UK rules, passengers would still be owed meals and accommodations in addition to rebooking,” said Lukács. American Airlines is giving passengers until Wednesday to change flights, with new travel allowed through Nov. 21.
“I will invest more in other si companies.
Noting Microsoft’s alert system appeared not to work, Moussouris said: “Something really bad must have happened that the cascade was not only as long lasting, but they couldn’t recover.”
As the outage entered its second day — disrupting a wide range of Microsoft 365 services including Outlook, Teams and AI assistant Copilot — some users could still have “intermittent access issues or delayed email delivery as mitigation progresses across the remaining affected infrastructure,” Microsoft said.
Microsoft’s service page for its suite of products, including Microsoft 360 was buffering for nearly half an hour before telling users that their services may not be working.
In addition to serving as interim CEO while the company searches for a permanent replacement, the 59-year-old Kress will keep her roles as chief financial officer and executive vice president, Nvidia said in a Thursday statement.
Wall Street analysts told CNBC that if Huang is removed as CEO, the stock could fall by 20%.
Also by Emily Lang
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 29 articles by Emily Lang →

Topics

Bloomberg Chengdu Shengnuo Biopharm Co China FDA the Food and Drug Administration

Subjects

Bloomberg ORG · 4× FDA ORG · 4× China GPE · 3× Chengdu Shengnuo Biopharm Co ORG · 2× Eli Lilly ORG · 1× Michael Rogers PERSON · 1× Nanjing Chengong Pharmaceutical Co ORG · 1× Novo Nordisk ORG · 1× Post ORG · 1× the Food and Drug Administration ORG · 1×

Narrative

Employees at the facility were also hastily moving documents out of a lab and into a room across the hall, stuffing them into lockers, which cited documents obtained under a Freedom of Information Act request.
framing: mixed · carried by 1 article(s) · first seen 2026-10-15
The two companies were put on the FDA’s import list, meaning their products could be confiscated at the border.

Claims (18 extracted, 7 hedged)

Inspectors at the Food and Drug Administration found “gross contamination” at two factories in China that make components for GLP-1 weight-loss drugs — including mold and bug infestations, according to an explosive report. uncertain
that → find → report
Both facilities were operated by so-called compounding pharmacies that produce semaglutide and tirzepatide — the active ingredients in blockbuster weight-loss drugs from Novo Nordisk and Eli Lilly — for black-market versions of the drugs that aren’t approved for sale by safety regulators, according to Bloomberg. uncertain
that → operate → Bloomberg
At one facility operated by Chengdu Shengnuo Biopharm Co, inspectors found bugs in the ceiling along with moldy floors. asserted
inspectors → operate → floors
When US inspectors arrived, employees were pouring out product samples into sinks in a “seemingly coordinated effort,” according to the report. uncertain
employees → arrive → report
Employees at the facility were also hastily moving documents out of a lab and into a room across the hall, stuffing them into lockers, which cited documents obtained under a Freedom of Information Act request. asserted
which → move → request
Inspectors added that they weren’t able to recover all the documents. asserted
they → add → documents
At another factory owned by Nanjing Chengong Pharmaceutical Co,, staff had been buying active ingredients made by other factories and slapping their own company’s seal of approval on them without reviewing testing and safety documentation, according to another report. uncertain
staff → own → report
The two companies were put on the FDA’s import list, meaning their products could be confiscated at the border. uncertain
products → put → border
The actual drugs themselves were not tested. asserted
drugs → test → ?
According to Bloomberg, one of the manufacturers, Chengdu Shengnuo Biopharm Co said in a filing with China’s government that it has been “diligently implementing effective measures” to correct the problems. uncertain
it → accord → problems
The Post reached out to both labs in China and to the FDA. asserted
Post → reach → FDA
Neither immediately responded to requests for comment. asserted
Neither → respond → comment
Michael Rogers, a former investigator with the FDA, told Bloomberg that the report findings “suggest a serious accident waiting to happen.” asserted
findings → tell → accident
Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more. asserted
Report → start → news
Little is known about the safety of unregulated peptides. asserted
Little → know → peptides
The FDA is currently considering whether to allow compounding pharmacies overseas to produce different types of peptides. asserted
pharmacies → consider → peptides
According to Bloomberg, some operate under the theory that US law allows the sale of copycats. uncertain
law → accord → copycats
Nearly fifteen years ago, contaminated drugs — including a steroid shot for pain — from New England Compounding Pharmacy killed 64 people after infecting over 700 with meningitis. asserted
drugs → contaminate → meningitis
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support